ПОВ - Page 49

ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1(28)’2017 Loop // Protein Sci. — 2016. — 25 (2). — P. 499-510. 19. Schuliga M. The inflammatory actions of coagulant and fibrinolytic proteases in disease // Mediators Inflamm. — 2015. — P. 4376-95. 20. Shoji F., Yano T., Yoshino I., et al. The dynamics and clinical significance of alpha 2 plasmin inhibitor-plasmin complex and thrombin-antithrombin complex in postoperative pleural effusion following a pulmonary lobectomy // Surg. Today. — 2009. — 39 (4). — P. 320-5. PMID: 19319640 DOI: 10.1007/s00595-008-3865-9 21. Suh Y.S., Yu J., Kim B.C., et al. Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis // Cancer Res. Treat. — 2015. — 47 (4). — P. 718-26. DOI: 10.4143/crt.2014.064 22. Tang L., Han X. The urokinase plasminogen activator system in breast cancer invasion and metastasis // Biomedicine and Pharmacotherapy. — 2013. — 67 (2). — P. 179-182. PMID:23201006 DOI:10.1016/j. biopha.2012.10.003 23. Thomson C.A., Crane T.E., Miller A., et al. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) Study. Contemp. Clin. Trials. 2016, Jul 6; pii: S. 1551-7144 (16): 30105-7. [Epub ahead of print] PMID: 27394382 DOI:10.1016/j. cct.2016.07.005 24. Wang C.Y., Chen C.L., Tseng Y.L., et al. Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms // J. Biol. Chem. — 2012. — 287. — P. 32512-24. doi: 10.1074/jbc.M112.351957. [PMC free article] [PubMed] [Cross Ref] 25. Witzel I., Milde-Langosch K., Schmidt M., et al. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer // Onco. Targets Ther. — 2014. Nov. 28. — 7. — P. 2205-13. DOI: 10.2147/OTT.S65344. eCollection 2014. 26. Yamashita D., Kondo T., Ohue S., et al. miR340 suppresses the stem-like cell function of gliomainitiating cells by targeting tissue plasminogen activator // Cancer Res. — 2015. — 75 (6). — P. 1123-33. 48 Клинические исследования и опыт в онкологии